Damage to highly connected regions of white matter in the brain following injury is more predictive of cognitive impairment than damage to highly connected gray matter hubs.
Military and law enforcement personnel who are routinely exposed to low levels of blasts, such as from high-caliber firearms while training, have higher levels of biomarkers associated with TBI.
Morning bright light therapy improved both physical and mental health symptoms, including cognitive function and sleep quality, in veterans who suffered TBI.
Combining brain scan images with machine learning, researchers identified a number of brain changes following TBI that share similarities with Alzheimer's disease. The findings add to the growing body of evidence that the two conditions follow the same trajectories.
Following a TBI, the risk of having a stroke is significantly increased for the first four months post-injury. The risk of stroke remains elevated for up to five years following a head injury.
A newly developed reparative hydrogel, which researchers are dubbing "brain glue", protects against loss of brain tissue following a TBI and can aid in functional neural repair.
In veterans who suffered a TBI, lack of sleep was associated with enlarged perivascular spaces and an increase in post-concussive symptoms.
A single head injury can increase the risk of developing dementia, especially in women. Suffering more than one head injury increases the risk further, a new study reports.
Researchers have identified a new condition associated with TBI in some patients. Vestibular agnosia, the newly identified disorder, worsens balance problems and reduces vertigo perception and dizziness.
A novel non-invasive method merges acoustic imaging methods with new algorithms to explore changes in white and gray matter following head injury.
Two new studies advance understanding of how the brain encodes episodic memories. The findings have the potential to develop new avenues of treatment for memory loss associated with Alzheimer's disease and TBI.
Short-term exposure to an experimental drug reverses age-related memory decline and cognitive deficits in mice. The drug, ISRIB, has previously shown beneficial effects in treating memory loss associated with TBI and other neurological disorders.
